Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Biotechnol Bioeng ; 118(8): 3263-3268, 2021 08.
Article in English | MEDLINE | ID: mdl-33990942

ABSTRACT

Here, we report a bienzymatic cascade to produce ß-amino acids as an intermediate for the synthesis of the leading oral antidiabetic drug, sitagliptin. A whole-cell biotransformation using recombinant Escherichia coli coexpressing a esterase and transaminase were developed, wherein the desired expression level of each enzyme was achieved by promotor engineering. The small-scale reactions (30 ml) performed under optimized conditions at varying amounts of substrate (100-300 mM) resulted in excellent conversions of 82%-95% for the desired product. Finally, a kilogram-scale enzymatic reaction (250 mM substrate, 220 L) was carried out to produce ß-amino acid (229 mM). Sitagliptin phosphate was chemically synthesized from ß-amino acids with 82% yield and > 99% purity.


Subject(s)
Escherichia coli , Esterases , Genetic Engineering , Microorganisms, Genetically-Modified , Promoter Regions, Genetic , Sitagliptin Phosphate/metabolism , Transaminases , Escherichia coli/genetics , Escherichia coli/metabolism , Esterases/genetics , Esterases/metabolism , Microorganisms, Genetically-Modified/genetics , Microorganisms, Genetically-Modified/metabolism , Transaminases/genetics , Transaminases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...